3rd Quarter - Report
FORSCEY, PLLC for BARR LABORATORIES
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Opposition to changes in legal doctrines of inequitable conduct that would make it harder for generic drug firms to pursue invalidity claims; S. 1145 Patent Reform Act of 2007.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL A FORSCEY | Managing Partner |
Health Issues HCR
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL A FORSCEY | Managing Partner |
| JOHN STINSON | Partner |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.